IHH Annual Report 2024

Financial Statements Notes to the Financial Statements Name of subsidiary Place of incorporation and business Principal activities Effective ownership interest and voting interest 2024 % 2023 % Indirect subsidiaries (continued) Held through Parkway (Shanghai) Hospital Management Ltd.: Shanghai Shu Kang Hospital Investment Management Co., Ltd. People’s Republic of China Investment holding 70.10 70.10 Suzhou Industrial Park Yuan Hui Health Consulting Co., Ltd. (f.k.a. Suzhou Industrial Park Yuan Hui Clinic Co., Ltd.) People’s Republic of China Provision of medical and healthcare outpatient services 70.10 70.10 Held through Shanghai Shu Kang Hospital Investment Management Co., Ltd.: Shanghai Mai Kang Hospital Investment Management Co., Ltd. People’s Republic of China Investment holding 70.10 70.10 Held through Shanghai Mai Kang Hospital Investment Management Co., Ltd.: Chengdu Rui Rong Clinic Co., Ltd. People’s Republic of China Provision of medical and healthcare outpatient services 70.10 70.10 Shanghai Rui Pu Clinic Co., Ltd. People’s Republic of China Provision of medical and healthcare outpatient services 70.10 70.10 Shanghai Rui Xiang Clinic Co., Ltd. People’s Republic of China Provision of medical and healthcare outpatient services 70.10 70.10 Shanghai Rui Ying Clinic Co., Ltd. People’s Republic of China Provision of medical and healthcare outpatient services 70.10 70.10 Held through Northern TK Venture Pte. Ltd.: Fortis Healthcare Limited ^ India Operates multi-specialty hospitals 31.17 31.17 Held through Fortis Healthcare Limited: Hiranandani Healthcare Private Limited ^ India Operates a multi-specialty hospital 31.17 31.17 Fortis Hospotel Limited ##^(9) India Provision of medical and Clinical Establishment services 31.17 31.17 Adayu Mindfulness Limited ^ India Investment holding 31.17 31.17 Fortis Healthcare International Limited ##^ Mauritius Investment holding 31.17 31.17 Agilus Diagnostics Limited ^ India Operates a network of diagnostics centres 20.35 17.98 IHH Healthcare Berhad | Annual Report 2024 226 38. SUBSIDIARIES (continued)

RkJQdWJsaXNoZXIy NDgzMzc=